Why I’d ignore this FTSE 250 ‘super stock’ and what I’d buy instead

This stock’s numbers look enticing, but I’m worried about something. Here’s where I would invest.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I can remember when the share price of FTSE 250 firm Aggreko (LSE: AGK) was powering upwards and the provider of modular, mobile power generators looked like a high-quality outfit with robust and growing operations.

Indeed, from early 2009, the share price shot up by more than 500% over the following three-and-a-half years with business boosted by events such as the 2012 London Olympics. But the share price began a long decline from its peak at the end of summer that year and is now around 65% lower. By early 2016, the outlook statements had dropped their bullish tone and the company seemed braced for softer trading ahead.

Slipping earnings

The financial record over the past five years shows earnings generally falling annually and the dividend has been essentially flat. But the operational and share-price slide could have run its course. City analysts following the firm have pencilled in earnings rises for the current year and for 2020. The share-price chart shows something of a consolidation, suggesting the lows might be in. And one popular share research website has labelled Aggreko as a Super Stock because of its strong showing against value, quality and momentum indicators.

Meanwhile, the valuation isn’t as racy as it was in the days of vibrant trading I described earlier. With the share price close to 829p, the forward-looking price-to-earnings ratio for the current year is around 16 and the anticipated dividend yield about 3.3%.

However, I’m concerned by the way Aggreko struggled to maintain its earnings over the last few years. The company has revealed its vulnerability to market cycles, and if we see a general macroeconomic slump, I reckon earnings could fall off a cliff, taking the dividend and the share price down too.

What makes this company special?

To me, it’s not worth investing in any individual company share unless I believe the stock has the potential to outperform the general stock market. I’m uncertain about Aggreko’s ability to do that so I’m avoiding the shares. In this case, I’d rather look at other shares or invest in a low-cost, passive index tracker fund that follows the fortunes of the market.

There are many choices with trackers. Perhaps I’d go for the HSBC FTSE 250 Index Class S – Accumulation, tracking the FTSE 250 index of which Aggreko is a constituent. Or I could look at the Legal & General UK Index Class C – Accumulation, which follows the FTSE 350 index and comprises the shares in the FTSE 250 index and those in the FTSE 100 index of larger companies. Or maybe I’d track the UK’s largest public limited companies with the Legal & General UK 100 Index Trust Class C – Accumulation.

You’ll notice that all three of the tracker funds I’ve mentioned are the accumulation version rather than the income version. Accumulation trackers automatically reinvest the dividends back into your investment, which sets you on the path to compounding your money.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

2 industry-leading value stocks investors should consider buying

These value stocks are at the top of their respective industries, and look like current bargains with the potential to…

Read more »

Black father and two young daughters dancing at home
Investing Articles

Just released: our 3 top small-cap stocks to buy before August [PREMIUM PICKS]

Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

Read more »

Investing Articles

If I’d put £5k in a FTSE 100 index fund 10 years ago, here’s what I’d have now!

Charlie Carman explores the performance of the FTSE 100 index over the past decade and the merits of passive versus…

Read more »

Investing Articles

£15K stashed away? I could turn that into a second income worth £49 a day!

This Fool explains how she would look to gain a second income through investing in UK stocks, and the steps…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

With the Apple share price near an all-time high, would I be crazy to buy more?

After touching all-time highs yesterday, the Apple share price is on a roll. But is there still enough growth ahead…

Read more »

Investing Articles

Nvidia stock has fallen 13% from its 52-week high! What next?

Our writer explains why Nvidia stock has dipped recently and highlights some risks associated with investing in the AI leader…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

The AstraZeneca share price is up 88% in 5 years, but is it just getting started?

The AstraZeneca share price has had a great few years, as acquisitions and clinical trials delighted shareholders. So is there…

Read more »

Investing Articles

Here’s why I’m watching the Anglo American share price

The mining sector has always interested investors. But after a flat few years, I'm wondering what's next for the Anglo…

Read more »